Dyadic International Inc

Dyadic International Inc

DYAI · NASDAQ · Healthcare / Biotechnology

0.33USD-0.02 (-5.74%)

Price History

Full chart

Market Stats

Previous Close0.3501
Open0.35
Day Range0.32 – 0.35
52-Week Range0.34 – 1.60
Volume189.40K
Market Cap16.67M
P/E (TTM)0.00
Forward P/E15.82
EPS-0.21
Dividend Yield0.00%
Beta0.96
50-Day Avg0.7826
200-Day Avg0.8284

About

Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Mark A. Emalfarb
  • Employees5
  • Headquarters1044 North U.S. Highway One, Jupiter, FL, United States, 33477-5094, USA
  • Websitehttps://www.dyadic.com

Leadership

  • Mr. Mark A. EmalfarbFounder, CEO & Director · b. 1956
  • Mr. Joseph P. HazeltonPresident & COO · b. 1976
  • Ms. Ana Gómez RodriguezSecretary of the Board

Financials

Income Statement

Currency: USD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue211.27K16.74M15.88M15.38M13.28M13.12M21.42M8.44M10.25M15.60M17.13M12.52M315.71K592.89K758.42K1.30M1.68M1.60M2.40M2.93M2.90M3.50M1.23M
Growth (%)-+7823.84%-5.12%-3.14%-13.68%-1.24%+63.33%-60.61%+21.47%+52.21%+9.83%-26.91%-97.48%+87.79%+27.92%+70.81%+29.77%-4.71%+50.06%+21.90%-1.07%+20.58%-64.74%
Cost of Revenue175.44K12.83M12.86M11.35M12.16M11.30M5.65M6.25M6.37M7.62M9.72M8.18M124.01K516.16K680.20K1.03M1.46M1.42M1.94M2.12M1.98M1.19M2.32M
Gross Profit35.83K3.91M3.03M4.04M1.12M1.81M15.77M2.19M3.88M7.99M7.41M4.35M191.70K76.72K78.22K268.17K221.38K176.99K459.39K807.11K922.96K2.30M-1.09M
Gross Margin16.96%23.34%19.05%26.25%8.44%13.82%73.61%25.98%37.82%51.18%43.25%34.71%60.72%12.94%10.31%20.70%13.17%11.05%19.11%27.54%31.84%65.82%-88.25%
Operating Expense226.61K9.24M13.01M14.77M--7.14M--6.43M6.85M9.67M3.84M6.03M7.21M7.86M9.50M10.20M15.19M10.97M9.15M8.20M6.06M
Operating Income-190.78K-5.33M-9.99M-10.74M--8.62M--1.56M556.50K-5.32M-3.65M-5.96M-7.13M-7.59M-9.28M-10.03M-14.73M-10.17M-8.23M-5.90M-7.15M
Operating Margin-90.30%-31.82%-62.87%-69.78%--40.26%--10.00%3.25%-42.52%-1154.93%-1004.45%-939.70%-586.09%-552.18%-625.85%-612.67%-346.92%-283.90%-168.82%-579.88%
EBITDA-190.78K-4.87M-9.13M-9.91M-----1.82M726.69K-5.45M-1.47M-5.32M-2.20M-7.55M-9.23M-9.96M-11.14M-10.12M-8.15M-5.38M-6.91M
EBITDA Margin-90.30%-29.08%-57.50%-64.41%-----11.65%4.24%-43.53%-464.06%-897.71%-290.41%-582.88%-548.88%-621.96%-463.45%-345.21%-281.25%-153.95%-560.63%
Net Income-190.78K-6.08M-10.51M-10.88M--5.24M--1.35M-428.05K-5.98M65.79M-3.61M-2.14M-5.69M-8.31M-9.33M-13.07M-9.74M-6.80M-5.81M-7.36M
Net Income Margin-90.30%-36.32%-66.20%-70.74%--24.47%--8.65%-2.50%-47.75%20837.76%-608.67%-281.61%-439.36%-494.21%-582.13%-543.73%-332.23%-234.42%-166.19%-597.63%
R&D3.57M3.62M4.90M4.24M1.25M1.74M1.51M980.00K950.00K921.71K1.00M2.19M124.01K885.60K2.20M3.32M5.42M3.87M8.39M4.50M3.30M2.04M2.15M
R&D as % of Total Revenue1690.24%21.63%30.84%27.54%9.41%13.27%7.04%11.61%9.27%5.91%5.84%17.47%39.28%149.37%290.48%256.06%322.18%241.47%349.12%153.61%113.75%58.48%174.85%
Interest Expense190.78K597.91K710.54K594.16K000000686.02K683.21K11.16K909566.15K894.53K984.93K731.71K51.70K380.50K0427.97K455.90K
Interest Expense % of Total Revenue90.30%3.57%4.47%3.86%0.00%0.00%0.00%0.00%0.00%0.00%4.00%5.46%3.53%0.15%74.65%69.05%58.59%45.68%2.15%12.99%0.00%12.24%37.00%

Balance Sheet

Currency: USD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets16.48K32.72M23.75M45.14M26.09M10.43M14.36M10.23M10.30M12.88M14.94M8.54M76.67M58.70M50.74M43.30M37.45M30.07M21.30M13.71M8.22M9.93M9.95M
Total Liabilities90.57K8.15M8.38M16.95M12.59M8.97M7.40M7.79M11.10M11.09M12.37M10.80M2.87M1.01M768.89K849.64K1.59M1.63M2.91M2.63M2.34M7.46M8.71M
Total Equity-74.09K24.47M15.27M28.19M13.50M1.46M6.96M2.44M-800.00K1.79M2.57M-2.26M73.79M57.69M49.98M42.45M35.86M28.45M18.39M11.09M5.88M2.47M1.23M
Cash12.55K20.51M12.15M31.07M15.95M2.83M8.42M4.54M3.69M3.99M8.89M2.50M68.60M6.89M5.79M2.39M4.82M20.64M15.75M5.79M6.52M6.51M4.62M
Total Debt-3.43M267.59K2.57M2.41M2.43M1.42M5.42M8.42M8.42M8.24M16.27M--------136.93K5.07M5.06M
Net Debt-12.55K-17.08M-11.88M-28.50M-13.54M-400.00K-7.00M880.00K4.73M-3.99M-649.46K5.64M-68.60M-6.89M-5.79M-2.39M-4.82M-20.64M-15.75M-5.79M-6.38M-1.44M438.33K

Cash Flow

Currency: USD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-128.49K-5.92M-7.82M790.51K-15.11M-12.87M6.55M-7.64M-3.63M365.17K5.10M-6.20M-802.67K-6.04M-2.61M-4.41M-5.78M-6.57M-11.28M-8.08M-6.73M-3.97M-5.70M
Investing Cash Flow7.12K-101.38K-447.95K-859.58K9.00K-----103.94K-414.09K-252.61K66.83M-42.56M103.00K3.33M7.71M22.12M5.22M-2.37M7.45M-1.88M82.08K
Financing Cash Flow2.75M24.88M-97.76K18.99M500.00K--890.00K4.05M3.06M37.07K220.57K55.74K73.88K-13.12M-6.22M-2.30M550.19K255.47K1.23M543.59K05.85M4.96M
Capital Expenditure110.00K101.38K413.29K519.47K840.00K270.00K90.00K370.00K300.00K45.81K406.07K350.29K00002255540
Free Cash Flow-128.49K-6.02M-8.23M271.04K-15.95M-13.14M6.46M-8.01M-3.93M319.36K4.69M-6.55M-802.67K-6.04M-2.61M-4.41M-5.78M-6.57M-11.28M-8.08M-6.73M-3.97M-5.70M
FCF to OCF100.00%101.71%105.29%34.29%105.56%102.10%98.63%104.84%108.26%87.45%92.03%105.65%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%

Earnings

Report DateMay 17, 2005Aug 11, 2005Nov 14, 2005Mar 29, 2006May 15, 2006Aug 11, 2006Nov 9, 2006Apr 2, 2007May 11, 2009Nov 16, 2009Mar 3, 2010May 17, 2010Aug 13, 2010Nov 15, 2010Mar 10, 2011May 5, 2011Aug 5, 2011Nov 4, 2011Mar 28, 2012May 11, 2012Aug 14, 2012Nov 9, 2012Mar 8, 2013May 16, 2013Aug 9, 2013Nov 15, 2013Mar 14, 2014May 9, 2014Aug 15, 2014Nov 13, 2014Mar 12, 2015May 14, 2015Aug 14, 2015Nov 12, 2015Mar 30, 2016May 12, 2016Aug 11, 2016Nov 10, 2016Mar 15, 2017May 11, 2017Aug 10, 2017Nov 9, 2017Mar 27, 2018May 10, 2018Aug 9, 2018Nov 6, 2018Mar 27, 2019May 9, 2019Aug 13, 2019Nov 13, 2019Mar 30, 2020May 14, 2020Aug 13, 2020Nov 12, 2020Mar 30, 2021May 13, 2021Aug 12, 2021Nov 10, 2021Mar 29, 2022May 12, 2022Aug 10, 2022Nov 10, 2022Mar 29, 2023May 10, 2023Aug 9, 2023Nov 8, 2023Mar 28, 2024May 14, 2024Aug 13, 2024Nov 12, 2024Mar 26, 2025May 12, 2025Aug 13, 2025Nov 12, 2025Mar 31, 2026May 13, 2026Aug 12, 2026Nov 11, 2026
EPS Estimate---0.09-0.09-0.09-0.08-0.11-0.10--------------------------------------0.06-0.06--0.07-0.07-0.07-0.02-0.07-0.07-0.080.09-0.09-0.10-0.02-0.14-0.07-0.09-0.07-0.03-0.05-0.06-0.06-0.07-0.06-0.07-0.04--0.06-0.04-0.04-0.04-0.03-0.03
EPS Actual-0.14-0.10-0.11-0.12-0.10-0.13-0.10-0.120.07-0.02-0.15-0.04-0.05-0.04-0.05-0.05-0.02-0.04-0.04-0.020.12-0.01-0.04-0.050.10-0.05-0.02-0.05-0.05-0.03-0.05-0.01-0.010.061.61-0.020.01-0.03-0.060.07-0.05-0.05-0.02-0.07-0.06-0.06-0.02-0.08-0.10-0.06-0.07-0.08-0.10-0.09-0.07-0.12-0.14-0.06-0.15-0.09-0.12-0.06-0.070.03-0.07-0.06-0.08-0.07-0.07-0.01-0.05-0.07-0.06-0.06-0.04-0.05-0.06-
Surprise---22.22%-33.33%-11.11%-62.50%9.09%-20.00%-------------------------------------0.00%66.67%--42.86%14.29%0.00%-300.00%-42.86%-28.57%12.50%-233.33%-55.56%40.00%-650.00%35.71%-71.43%33.33%0.00%200.00%-40.00%0.00%-33.33%0.43%-16.67%85.71%-25.00%-0.00%-50.00%-11.03%-25.00%-100.00%-
Timing----After-hoursPre-marketAfter-hoursAfter-hours------------------------------------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap16.67M
Enterprise Value18.55M
Trailing P/E0.00
Forward P/E15.82
PEG Ratio0.00
Price / Sales4.38
Price / Book21.01
EPS-0.21
Book Value-0.066
Revenue (TTM)3.80M
Gross Profit (TTM)617.62K
Profit Margin-200.46%
Operating Margin-212.82%
Return on Equity-2826.92%
Return on Assets-62.99%
Shares Outstanding40.06M
Shares Float27.50M
Beta0.96
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 1 analystsTarget 5.50
  • Buy
    1

Ownership Breakdown

Institutions
12.32%
Insiders
22.90%
Retail / Other
64.78%

Top Institutional Holders

  • Apis Capital Advisors, LLC
    1.27M3.17%
  • Vanguard Capital Management, LLC
    928.23K2.32%
  • Chapin Davis Inc
    888.00K2.22%
  • BB&T Corp.
    326.20K0.81%
  • Geode Capital Management, LLC
    313.51K0.78%
  • BlackRock Inc
    275.43K0.69%
  • Vanguard Fiduciary Trust Co
    139.48K0.35%
  • Marathon Capital Management LLC
    110.00K0.27%
  • Sage Mountain Advisors LLC
    106.56K0.27%
  • Renaissance Technologies Corp
    81.67K0.20%
  • HighTower Advisors, LLC
    79.47K0.20%
  • Citadel Advisors Llc
    74.34K0.19%
  • AlphaCore Capital LLC
    72.31K0.18%
  • LANDSCAPE CAPITAL MANAGEMENT,LLC
    55.26K0.14%
  • AE Wealth Management LLC
    53.76K0.13%
  • Perkins Capital Management Inc
    48.05K0.12%
  • State Street Corp
    42.55K0.11%
  • Appleseed Capital
    41.74K0.10%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    583.63K1.61%
  • Fidelity Extended Market Index
    126.36K0.35%